Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 55, Issue 10, 2006, Pages 1382-1387

  Araiza, Paul ^a   Hewes, Hilary ^a   Gashetewa, Carrie ^a   Vella, Chantal A ^a   Burge, Mark R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIABETES CONTROL; ENERGY; EXERCISE; FEMALE; GLYCEMIC CONTROL; HUMAN; INFORMATION PROCESSING; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PEDOMETER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WALKING;

ADULT; AGED; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; EXERCISE; EXERCISE THERAPY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OXIDATIVE STRESS; PATIENT COMPLIANCE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS;

EID: 33748455432     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.06.009     Document Type: Article

References (30)

1. Mayer-Davis E.J., D'Agostino Jr. R., Karter A.J., et al. Intensity and amount of physical activity in relation to insulin sensitivity. JAMA 279 (1988) 669-674
2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
3. Helmrich S.P., Ragland D.R., Leung R.W., et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325 (1991) 147-152
4. Boule N.G., Haddad E., Kenny G.P., et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus. JAMA 286 (2001) 1218-1227
5. Schneider S.H., Amorosa L.F., Khachadurian A.K., et al. Studies on the mechanism of improved glucose control during regular exercise in type 2 diabetes. Diabetologia 26 (1984) 355-360
6. Yamanouchi K., Shinozaki T., Chikada K., et al. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 18 (1995) 775-778
7. Bruce C.R., Kriketos A.D., Cooney G.J., et al. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47 (2004) 23-30
8. Gregg E.W., Gerzoff R.B., and Caspersen C.J. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 163 (2003) 1440-1447
9. Beller G.A. Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities. Circulation 103 (2001) 2428-2435
10. Hardman A.E., and Hudson A. Brisk walking and serum lipid and lipoprotein variables in previously sedentary women-effect of 12 weeks of regular brisk walking followed by 12 weeks of detraining. Br J Sports Med 28 (1994) 261-266
11. Huttunen J.K., Lansimies E., Voutilainen E., et al. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation 60 (1979) 1220-1229
12. Kokkinos P.F., and Fernhall B. Physical activity and high density lipoprotein cholesterol levels what is the relationship?. Sports Med 28 (1999) 307-314
13. Angelopoulos T.J., Lewis R., Jamurtas T., et al. Significant changes in VLDL-triacylglycerol and glucose tolerance in obese subjects following ten days of training. Eur J Appl Physiol Occup Physiol 77 (1998) 556-559
14. Dumortier M., Brandou F., Perez-Martin A., et al. Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes Metab 29 (2003) 509-518
15. Iwane M., Arita M., Tomimoto S., et al. Walking 10,000 steps per day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertens Res 23 (2000) 273-580
16. Swartz A.M., Strath S.J., Bassett Jr. D.R., et al. Increasing daily walking improves glucose tolerance in overweight women. Prev Med 37 (2003) 356-362
17. Walker K.Z., Piers L.S., Putt R.S., et al. Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care 22 (1999) 555-561
18. Zinman B., Ruderman N., Campaigne B.N., et al. Physical activity/exercise and diabetes. Diabetes Care 27 Suppl 1 (2004) S58-S62
19. Houmard J.A., Tanner C.J., Slentz C.A., et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 96 (2004) 101-106
20. Nishida Y., Tokuyama K., Nagasaka S., et al. Effect of moderate exercise training on peripheral glucose effectiveness, insulin sensitivity, and endogenous glucose production in healthy humans estimated by a two-compartment-labeled minimal model. Diabetes 53 (2004) 315-320
21. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273 (1995) 402-407
22. Tudor-Locke C., and Bassett Jr. D.R. How many steps per day are enough?. Sports Med 34 (2004) 1-8
23. LeMasurier G.C., Sidman C.L., and Corbin C.B. Accumulating 10,000 steps: does this meet current physical activity guidelines?. Res Q Exerc Sport 74 (2003) 389-394
24. Katsuki A., Sumida Y., Gabazza E., et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24 (2001) 362-365
25. Tudor-Locke C., Bell R.C., Myers A.M., et al. Controlled outcome evaluation of the first step program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes 28 (2004) 113-119
26. Maehlm S., Grandmontagne M., Newsholme E.A., et al. Magnitude and duration of excess post exercise oxygen consumption in healthy young subjects. Metabolism 35 (1986) 425-429
27. Lindahl B., Nilsson T.K., Asplund K., et al. Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism 47 (1998) 384-390
28. Szymanski L.M., Pate R.R., and Durstine J.L. Effects of maximal exercise and venous occlusion on fibrinolytic activity in physically active and inactive men. J Appl Physiol 77 (1994) 2305-2310
29. Bodary P.F., Yasuda N., Watson D.D., et al. Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1). Med Sci Sports Exerc 35 (2003) 1853-1858
30. Janand-Delenne B., Chagnaud C., Raccah D., et al. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 22 (1998) 312-317